Effects of GABAA receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Effects of GABAA receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions. / Hansen, Suzanne L.; Ebert, B.; Fjalland, Bjarne; Kristiansen, Uffe.

In: British Journal of Pharmacology, Vol. 133, No. 4, 2001, p. 539-549.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hansen, SL, Ebert, B, Fjalland, B & Kristiansen, U 2001, 'Effects of GABAA receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions', British Journal of Pharmacology, vol. 133, no. 4, pp. 539-549. https://doi.org/10.1038/sj.bjp.0704121

APA

Hansen, S. L., Ebert, B., Fjalland, B., & Kristiansen, U. (2001). Effects of GABAA receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions. British Journal of Pharmacology, 133(4), 539-549. https://doi.org/10.1038/sj.bjp.0704121

Vancouver

Hansen SL, Ebert B, Fjalland B, Kristiansen U. Effects of GABAA receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions. British Journal of Pharmacology. 2001;133(4):539-549. https://doi.org/10.1038/sj.bjp.0704121

Author

Hansen, Suzanne L. ; Ebert, B. ; Fjalland, Bjarne ; Kristiansen, Uffe. / Effects of GABAA receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions. In: British Journal of Pharmacology. 2001 ; Vol. 133, No. 4. pp. 539-549.

Bibtex

@article{181332483cf641c0a2851181a2c8d239,
title = "Effects of GABAA receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions",
abstract = "Based on an unexpected high maximum response to piperidine-4-sulphonic acid (P4S) at human α1α6β2γ2 GABAA receptors expressed in Xenopus oocytes attempts to correlate this finding with the pharmacological profile of P4S and other GABAA receptor ligands in neuronal cultures from rat cerebellar granule cells and rat cerebral cortex were carried out. GABA and isoguvacine acted as full and piperidine-4-sulphonic acid (P4S) as partial agonists, respectively, at α1β2γ2, α6β2γ2 and α1α6β2γ2 GABA receptors expressed in Xenopus oocytes with differences in potency. Whole-cell patch-clamp recordings were used to investigate the pharmacological profile of the partial GABAA receptor agonists 4,5,6,7-tetrahydroisoxazolo-(5,4-c)pyridin-3-ol (THIP), P4S, 5-(4-piperidyl)isoxazol-3-ol (4-PIOL), and 3-(4-piperidyl)isoxazol-5-ol (iso-4-PIOL), and the competitive GABAA receptor antagonists Bicuculline Methbromide (BMB) and 2-(3-carboxypropyl)-3-amino-6-methoxyphenyl-pyridazinium bromide (SR95531) on cerebral cortical and cerebellar granule neurons. In agreement with findings in oocytes, GABA, isoguvacine and P4S showed similar pharmacological profiles in cultured cortical and cerebellar neurones, which are known to express mainly αl, α2, α3, and α5 containing receptors and α1, α6 and α1α6 containing receptors, respectively. 4-PIOL and iso-4-PIOL, which at GABAA receptors expressed in oocytes were weak antagonists, showed cell type dependent potency as inhibitors of GABA mediated responses. Thus, 4-PIOL was slightly more potent at cortical neurones than at granule neurones and iso-4-PIOL was more potent in inhibiting isoguvacine-evoked currents at cortical than at granule neurons. Furthermore the maximum response to 4-PIOL corresponded to that of a partial agonist, whereas that of iso-4-PIOL gave a maximum response close to zero. It is concluded that the pharmacological profile of partial agonists is highly dependent on the receptor composition, and that small structural changes of a ligand can alter the selectivity towards different subunit compositions. Moreover, this study shows that pharmacological actions determined in oocytes are generally in agreement with data obtained from cultured neurons.",
keywords = "Antagonists, Cerebellar granule neurons, Cerebral cortical neurons, Efficacy, Partial agonists, Potency, Subunits, Two-electrode voltage-clamp, Whole-cell patch-clamp, Xenopus oocytes",
author = "Hansen, {Suzanne L.} and B. Ebert and Bjarne Fjalland and Uffe Kristiansen",
year = "2001",
doi = "10.1038/sj.bjp.0704121",
language = "English",
volume = "133",
pages = "539--549",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley",
number = "4",

}

RIS

TY - JOUR

T1 - Effects of GABAA receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions

AU - Hansen, Suzanne L.

AU - Ebert, B.

AU - Fjalland, Bjarne

AU - Kristiansen, Uffe

PY - 2001

Y1 - 2001

N2 - Based on an unexpected high maximum response to piperidine-4-sulphonic acid (P4S) at human α1α6β2γ2 GABAA receptors expressed in Xenopus oocytes attempts to correlate this finding with the pharmacological profile of P4S and other GABAA receptor ligands in neuronal cultures from rat cerebellar granule cells and rat cerebral cortex were carried out. GABA and isoguvacine acted as full and piperidine-4-sulphonic acid (P4S) as partial agonists, respectively, at α1β2γ2, α6β2γ2 and α1α6β2γ2 GABA receptors expressed in Xenopus oocytes with differences in potency. Whole-cell patch-clamp recordings were used to investigate the pharmacological profile of the partial GABAA receptor agonists 4,5,6,7-tetrahydroisoxazolo-(5,4-c)pyridin-3-ol (THIP), P4S, 5-(4-piperidyl)isoxazol-3-ol (4-PIOL), and 3-(4-piperidyl)isoxazol-5-ol (iso-4-PIOL), and the competitive GABAA receptor antagonists Bicuculline Methbromide (BMB) and 2-(3-carboxypropyl)-3-amino-6-methoxyphenyl-pyridazinium bromide (SR95531) on cerebral cortical and cerebellar granule neurons. In agreement with findings in oocytes, GABA, isoguvacine and P4S showed similar pharmacological profiles in cultured cortical and cerebellar neurones, which are known to express mainly αl, α2, α3, and α5 containing receptors and α1, α6 and α1α6 containing receptors, respectively. 4-PIOL and iso-4-PIOL, which at GABAA receptors expressed in oocytes were weak antagonists, showed cell type dependent potency as inhibitors of GABA mediated responses. Thus, 4-PIOL was slightly more potent at cortical neurones than at granule neurones and iso-4-PIOL was more potent in inhibiting isoguvacine-evoked currents at cortical than at granule neurons. Furthermore the maximum response to 4-PIOL corresponded to that of a partial agonist, whereas that of iso-4-PIOL gave a maximum response close to zero. It is concluded that the pharmacological profile of partial agonists is highly dependent on the receptor composition, and that small structural changes of a ligand can alter the selectivity towards different subunit compositions. Moreover, this study shows that pharmacological actions determined in oocytes are generally in agreement with data obtained from cultured neurons.

AB - Based on an unexpected high maximum response to piperidine-4-sulphonic acid (P4S) at human α1α6β2γ2 GABAA receptors expressed in Xenopus oocytes attempts to correlate this finding with the pharmacological profile of P4S and other GABAA receptor ligands in neuronal cultures from rat cerebellar granule cells and rat cerebral cortex were carried out. GABA and isoguvacine acted as full and piperidine-4-sulphonic acid (P4S) as partial agonists, respectively, at α1β2γ2, α6β2γ2 and α1α6β2γ2 GABA receptors expressed in Xenopus oocytes with differences in potency. Whole-cell patch-clamp recordings were used to investigate the pharmacological profile of the partial GABAA receptor agonists 4,5,6,7-tetrahydroisoxazolo-(5,4-c)pyridin-3-ol (THIP), P4S, 5-(4-piperidyl)isoxazol-3-ol (4-PIOL), and 3-(4-piperidyl)isoxazol-5-ol (iso-4-PIOL), and the competitive GABAA receptor antagonists Bicuculline Methbromide (BMB) and 2-(3-carboxypropyl)-3-amino-6-methoxyphenyl-pyridazinium bromide (SR95531) on cerebral cortical and cerebellar granule neurons. In agreement with findings in oocytes, GABA, isoguvacine and P4S showed similar pharmacological profiles in cultured cortical and cerebellar neurones, which are known to express mainly αl, α2, α3, and α5 containing receptors and α1, α6 and α1α6 containing receptors, respectively. 4-PIOL and iso-4-PIOL, which at GABAA receptors expressed in oocytes were weak antagonists, showed cell type dependent potency as inhibitors of GABA mediated responses. Thus, 4-PIOL was slightly more potent at cortical neurones than at granule neurones and iso-4-PIOL was more potent in inhibiting isoguvacine-evoked currents at cortical than at granule neurons. Furthermore the maximum response to 4-PIOL corresponded to that of a partial agonist, whereas that of iso-4-PIOL gave a maximum response close to zero. It is concluded that the pharmacological profile of partial agonists is highly dependent on the receptor composition, and that small structural changes of a ligand can alter the selectivity towards different subunit compositions. Moreover, this study shows that pharmacological actions determined in oocytes are generally in agreement with data obtained from cultured neurons.

KW - Antagonists

KW - Cerebellar granule neurons

KW - Cerebral cortical neurons

KW - Efficacy

KW - Partial agonists

KW - Potency

KW - Subunits

KW - Two-electrode voltage-clamp

KW - Whole-cell patch-clamp

KW - Xenopus oocytes

UR - http://www.scopus.com/inward/record.url?scp=0034962851&partnerID=8YFLogxK

U2 - 10.1038/sj.bjp.0704121

DO - 10.1038/sj.bjp.0704121

M3 - Journal article

C2 - 11399671

AN - SCOPUS:0034962851

VL - 133

SP - 539

EP - 549

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 4

ER -

ID: 276332626